Purchases and Sales Made in Q2 2021 in Entasis Therapeutics Holdings Inc. (ETTX)
This table provides information about the institutional ownership of Entasis Therapeutics Holdings Inc. (ETTX) during Q2 2021. The information is specifically focused on institutions that hold shares of Entasis Therapeutics Holdings Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Aug 13, 2021
Q2 2021
|
Vanguard Group Inc
Valley Forge, PA |
BUY
|
- |
420KNew |
$764K - $1.28M
|
420K
$0
|
|
|
Aug 16, 2021
Q2 2021
|
David A. Siegel
Two Sigma Advisers, LP | New York, Ny
|
BUY
|
- |
163KNew |
$297K - $495K
|
163K
$0
|
|
|
Aug 16, 2021
Q2 2021
|
Alberta Investment Management Corp
Edmonton, A0 |
BUY
|
- |
130KNew |
$237K - $395K
|
130K
$0
|
|
|
Aug 16, 2021
Q2 2021
|
Two Sigma Investments, LP
New York, NY |
BUY
|
- |
125K+ 317.24% |
$227K - $380K
|
164K
$0
|
|
|
Aug 16, 2021
Q2 2021
|
State Street Corp
Boston, MA |
BUY
|
- |
39.2KNew |
$71.4K - $119K
|
39.2K
$0
|
|
|
Aug 11, 2021
Q2 2021
|
Black Rock Inc.
New York, NY |
BUY
|
- |
32.8KNew |
$59.6K - $99.6K
|
32.8K
$0
|
|
|
Aug 11, 2021
Q2 2021
|
Acadian Asset Management LLC
Boston, MA |
BUY
|
- |
31.8KNew |
$57.9K - $96.7K
|
31.8K
$0
|
|
|
Aug 13, 2021
Q2 2021
|
Geode Capital Management, LLC
Boston, MA |
BUY
|
- |
28.4K+ 53.94% |
$51.7K - $86.4K
|
81.1K
$0
|
|
|
Aug 02, 2021
Q2 2021
|
Advisor Group Holdings, Inc.
Phoenix, AZ |
BUY
|
- |
2.1KNew |
$3.82K - $6.38K
|
2.1K
$0
|
|
|
Aug 13, 2021
Q2 2021
|
Ubs Group Ag
|
BUY
|
- |
103New |
$187 - $313
|
103
$0
|
|
|
Aug 13, 2021
Q2 2021
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
|
Aug 13, 2021
Q2 2021
|
Barclays PLC
London, X0 |
SELL
|
- |
-112Closed |
$204 - $340
|
0
$0
|
|
|
Aug 16, 2021
Q2 2021
|
Federated Hermes, Inc.
Pittsburgh, PA |
SELL
|
- |
-566Closed |
$1.03K - $1.72K
|
0
$0
|
|
|
Jul 26, 2021
Q2 2021
|
Janney Montgomery Scott LLC
|
SELL
|
- |
-1.44K- 2.03% |
$2.63K - $4.39K
|
69.5K
$0
|
|
|
Aug 16, 2021
Q2 2021
|
Wells Fargo & Company
San Francisco, CA |
SELL
|
- |
-2K- 55.92% |
$3.63K - $6.07K
|
1.57K
$0
|
|
|
Aug 16, 2021
Q2 2021
|
Occudo Quantitative Strategies LP
Fort Lauderdale, FL |
SELL
|
- |
-5.97K- 20.57% |
$10.9K - $18.2K
|
23.1K
$0
|
|
|
Aug 16, 2021
Q2 2021
|
Bridgeway Capital Management, LLC
Houston, TX |
SELL
|
- |
-10K- 8.33% |
$18.2K - $30.4K
|
110K
$0
|
|
|
Aug 16, 2021
Q2 2021
|
Granahan Investment Management, LLC
Waltham, MA |
SELL
|
- |
-10.1KClosed |
$18.3K - $30.6K
|
0
$0
|
|
|
Aug 16, 2021
Q2 2021
|
Tower Research Capital LLC (Trc)
New York, NY |
SELL
|
- |
-13.9KClosed |
$25.3K - $42.3K
|
0
$0
|
|
|
Aug 11, 2021
Q2 2021
|
Susquehanna Fundamental Investments, LLC
Bala Cynwyd, PA |
SELL
|
- |
-19.8K- 47.24% |
$36K - $60.1K
|
22.1K
$0
|
|
|
Aug 16, 2021
Q2 2021
|
Squarepoint Ops LLC
New York, NY |
SELL
|
- |
-91.7KClosed |
$167K - $279K
|
0
$0
|
|
|
Aug 13, 2021
Q2 2021
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
SELL
|
- |
-395K- 50.21% |
$719K - $1.2M
|
392K
$0
|
|
|
Aug 16, 2021
Q2 2021
|
Pivotal Bio Venture Partners Investment Advisor LLC
San Francisco, CA |
SELL
|
- |
-1.18MClosed |
$2.14M - $3.58M
|
0
$0
|